drugset / Trial / NCT02203500

Tolerability and Pharmacokinetics of Lacidipine With and Without the Co-administration of Telmisartan in Female and Male Healthy Subjects

NCT02203500

Phase 1 Completed 26 enrolled Boehringer Ingelheim
RandomizedCrossoverOpen-labelTreatment

Summary

The objectives of this study are to compare the steady state pharmacokinetics of lacidipine with and without the co-administration of telmisartan and to compare the steady state pharmacokinetics of telmisartan with and without the co-administration of lacidipine

Timeline

Start
1998-10
Primary completion
1999-01
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Lacidipine Small molecule 6 mg
Subject Telmisartan Other / unclassified 80 mg

Indications

No indication recorded.